06/22 | ADRs End Lower; ArcelorMittal, AstraZeneca Trade Actively | DJ |
06/22 | Biocartis, AstraZeneca To Jointly Develop Companion Lung Cancer Diagnostic Test For Tag.. | MT |
06/22 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces New Agreement with AstraZeneca for .. | GL |
06/22 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces New Agreement with AstraZeneca for .. | AQ |
06/22 | Biocartis Group NV Announces New Agreement with Astrazeneca for the Development and Mar.. | CI |
06/20 | Molecular Diagnostics Group Biocartis Introduces Lung Cancer Testing Panel | MT |
06/20 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Launch of its Rapid CE-marked IVD I.. | GL |
06/20 | Biocartis Group NV Announces Launch of its Rapid CE-marked IVD Idylla GeneFusion Panel .. | CI |
06/20 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Launch of its Rapid CE-marked IVD I.. | GL |
06/15 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Reaches Key Commercial Milestones: One-Millio.. | GL |
06/15 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Reaches Key Commercial Milestones: One-Millio.. | AQ |
05/13 | PRESS RELEASE BIOCARTIS GROUP NV : Results of the Annual Shareholders' Meeting held on 13 .. | GL |
05/04 | PRESS RELEASE BIOCARTIS GROUP NV : New Study Led by Memorial Sloan Kettering Cancer Center.. | GL |
05/04 | PRESS RELEASE BIOCARTIS GROUP NV : New Study Led by Memorial Sloan Kettering Cancer Center.. | GL |
05/04 | Biocartis Group NV announces New Study Led by Memorial Sloan Kettering Cancer Center (N.. | CI |
04/25 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Presentation of Three Idylla™.. | GL |
04/25 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Presentation of Three Idylla™.. | GL |
04/21 | PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces Presentation of First Prospective Vali.. | AQ |
04/21 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Reports Results of First Quarter of 2022: On .. | AQ |
04/21 | Biocartis Group NV Reconfirms Earnings Guidance of 2022 | CI |
04/12 | PRESS RELEASE BIOCARTIS GROUP NV : Invitation to the Annual Shareholders' Meeting | GL |
03/31 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Publication of 2021 Annual Report | GL |
02/24 | BIOCARTIS : Webcast presentation full year 2021 results | PU |
02/24 | TRANSCRIPT : Biocartis Group NV, 2021 Earnings Call, Feb 24, 2022 | CI |
02/24 | BIOCARTIS : Announces 2021 results and 2022 outlook | PU |
02/24 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces 2021 results and 2022 outlook | GL |
02/24 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces 2021 results and 2022 outlook | GL |
02/24 | Biocartis Group NV Provides Earnings Guidance for the Year 2022 | CI |
02/24 | Biocartis Group NV Reports Earnings Results for the Full Year Ended December 31, 2021 | CI |
02/17 | BIOCARTIS : Announces 2021 full year results on 24 february 2022 | PU |
02/17 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces 2021 full year results on 24 febru.. | AQ |
02/08 | Biocartis, Ophiomics to Jointly Commercialize Liver Cancer Test | MT |
02/08 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis and Ophiomics to Collaborate on Liver Cancer.. | AQ |
02/08 | Biocartis and Ophiomics to Collaborate on Liver Cancer Test | CI |
02/04 | PRESS RELEASE BIOCARTIS GROUP NV : Disclosure of a transparency notification | AQ |
01/25 | Biocartis' Lung Cancer Test Shown to Improve Patient Survival Rates in UK Study | MT |
01/25 | PRESS RELEASE BIOCARTIS GROUP NV : Large UK Study Shows Rapid EGFR Testing with Idylla&tra.. | AQ |
01/25 | Biocartis Group NV Announces Publication of Large New Study Comparing the Difference in.. | CI |
01/10 | BIOCARTIS : Meets 2021 key objectives | PU |
01/10 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis meets 2021 key objectives | AQ |
2021 | Biocartis' COVID-19 Tests Found to Detect Omicron Variant | MT |
2021 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis' Idylla™ SARS-CoV-2 testing Successfull.. | AQ |
2021 | Biocartis Idylla SARS-CoV-2 Testing Successfully Detects Omicron Variant | CI |
2021 | PRESS RELEASE BIOCARTIS GROUP NV : SeptiCyte® RAPID Receives 510(k) clearance by US FDA | AQ |
2021 | Biocartis Group NV Announces SeptiCyte? Rapid Receives 510(K) Clearance by US FDA | CI |
2021 | Biocartis' Epidermal Growth Factor Receptor Mutation Test Shows Reduced Patient Managem.. | MT |
2021 | PRESS RELEASE BIOCARTIS GROUP NV : New Study Demonstrates Idylla™ EGFR Mutation Test.. | AQ |
2021 | Biocartis Group NV Announces the Publication of New Study that Demonstrates That the Id.. | CI |
2021 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Q3 2021 Business Update | AQ |
2021 | BIOCARTIS : Disclosure of a transparency notification | PU |
2021 | PRESS NEWS BIOCARTIS GROUP NV : Disclosure of a transparency notification | AQ |
2021 | BIOCARTIS : Restarts Production Of ML2 Manufacturing Line | MT |
2021 | BIOCARTIS : Announces Restart of its High-Throughput Cartridge Manufacturing Line | PU |
2021 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Restart of its High-Throughput Cart.. | AQ |
2021 | Biocartis Group NV Announces Restart of Its High-Throughput Cartridge Manufacturing Lin.. | CI |
2021 | BIOCARTIS : Disclosure of a transparency notification | PU |
2021 | PRESS RELEASE BIOCARTIS GROUP NV : Disclosure of a transparency notification | AQ |
2021 | BIOCARTIS : Webcast presentation H1 2021 results | PU |
2021 | TRANSCRIPT : Biocartis Group NV, H1 2021 Earnings Call, Sep 02, 2021 | CI |
2021 | BIOCARTIS : Launches Idylla™ SARS-CoV-2/Flu/RSV Panel | PU |
2021 | BIOCARTIS : announces H1 2021 results | PU |
2021 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces H1 2021 results | AQ |
2021 | Biocartis Group Nv Reports Earnings Results for the Half Year Ended June 30, 2021 | CI |
2021 | PRESS NEWS BIOCARTIS GROUP NV : Biocartis Launches Idylla™ SARS-CoV-2/Flu/RSV Panel | AQ |
2021 | Biocartis Group NV Launches Idylla™ SARS-CoV-2/Flu/RSV Panel | CI |
2021 | BIOCARTIS : Disclosure of a transparency notification | PU |
2021 | PRESS RELEASE BIOCARTIS GROUP NV : Disclosure of a transparency notification | AQ |
2021 | BIOCARTIS : Announces 2021 half-year results on 2 september 2021 | PU |
2021 | PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces 2021 half-year results on 2 septem.. | AQ |
2021 | PRESS RELEASE BIOCARTIS GROUP NV : Second Update on Fire Incident at Biocartis Warehouse | AQ |
2021 | Biocartis Group NV Provides Update on Resumption of Production at ML2 line | CI |
2021 | BIOCARTIS : Manufacturing Capacity Impaired Following Belgian Warehouse Fire | MT |
2021 | BIOCARTIS : Update on Fire Incident at Biocartis Warehouse | PU |
2021 | PRESS NEWS BIOCARTIS GROUP NV : Update on Fire Incident at Biocartis Warehouse | AQ |
2021 | BIOCARTIS : Fire Incident at Biocartis Warehouse in Mechelen, Belgium | PU |